Ulf Eriksson
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 0.5%
- Angiogenesis and VEGF in Cancer
- Retinoids in leukemia and cellular processes
- Retinal Development and Disorders
Papers in
-
- Cancer, Hypoxia, and Metabolism 16
- Protease and Inhibitor Mechanisms 8
-
- Retinoids in leukemia and cellular processes 42
- Angiogenesis and VEGF in Cancer 35
- Retinal Development and Disorders 18
- Co-authors
- Kari AlitaloXuri LiLinda FredrikssonChrister BetsholtzAnnelie FalkevallHong LiCarolina E. HagbergKristian Pietras
- Journals
- Journal of Biological Chemistry (14 papers)PLoS ONE (7 papers)American Journal Of Pathology (6 papers)Experimental Cell Research (6 papers)Circulation (5 papers)
- Partner nations
- SwedenUnited StatesFinland
In The Last Decade
Ulf Eriksson
147 papers receiving 14.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Cancer Research 2.1k
- Molecular Biology 9.0k
- Biochemistry 636
- Oncology 2.5k
- Neurology 750
Countries citing papers authored by Ulf Eriksson
This map shows the geographic impact of Ulf Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Eriksson more than expected).
Fields of papers citing papers by Ulf Eriksson
This network shows the impact of papers produced by Ulf Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Eriksson. The network helps show where Ulf Eriksson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ulf Eriksson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2016 | 37 | |
| 3 | 2016 | 42 | |
| 4 | 2015 | 44 | |
| 5 | 2013 | 73 | |
| 6 | 2013 | 51 | |
| 7 | 2010 | 34 | |
| 8 | 2009 | 30 | |
| 9 | 2008 | 17 | |
| 10 | 2005 | 46 | |
| 11 | 2003 | 44 | |
| 12 | 2001 | 94 | |
| 13 | 1998 | 277 | |
| 14 | VEGF-B binds to VEGFR-1 and regulates plasminogen activator activity in endothelial cells | 1998 | 6 |
| 15 | 1997 | 379 | |
| 16 | 1997 | 29 | |
| 17 | 1996 | 31 | |
| 18 | 1996 | 167 | |
| 19 | 1993 | 12 | |
| 20 | 1992 | 105 |
About Ulf Eriksson
Ulf Eriksson is a scholar working on Cancer Research, Molecular Biology, Biochemistry, Immunology and Allergy and Cell Biology, having authored 149 papers that have together received 14.3k indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (42 papers), Angiogenesis and VEGF in Cancer (35 papers), Retinal Development and Disorders (18 papers), Cancer, Hypoxia, and Metabolism (16 papers), Lymphatic System and Diseases (12 papers), Biotin and Related Studies (9 papers), Protease and Inhibitor Mechanisms (8 papers) and Cell Adhesion Molecules Research (8 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (9.0k citations), Biochemistry (636 citations), Oncology (2.5k citations) and Neurology (750 citations). Ulf Eriksson has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Kari Alitalo, Xuri Li, Linda Fredriksson, Christer Betsholtz, Annelie Falkevall, Hong Li, Carolina E. Hagberg, Kristian Pietras, Lars Muhl and Arne Östman. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE, American Journal Of Pathology, Experimental Cell Research and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.